EUVIMEDEUVIMED entdecken
Crossref

Neuropathology-defined Alzheimer's disease transcriptomic programs converge in blood at mild cognitive impairment

Songnian Lu, Hongyuan Mao, Xiaoya Rui, Xiaohui Hou, Mengcen Qian, Xingjiao Wu

Journal of Alzheimer’s Disease · 19.11.2026

DOI: 10.1177/13872877261507716 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 19.11.2026. Verfasst von Songnian Lu und 5 weiteren Autor:innen. Die Arbeit nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Blood transcriptomic studies in Alzheimer's disease (AD) often train signatures directly in blood, making it unclear whether signals reflect brain disease programs, blood-cell composition, or cohort structure.

Objective

To test how neuropathology-defined AD transcriptional programs appear in blood, whether distinct brain programs show a shared peripheral pattern, and whether that pattern is most evident during mild cognitive impairment (MCI).

Methods

Three directional gene sets were derived before blood analysis from postmortem brain RNA-seq (GSE278723) to represent amyloid-associated, neurodegeneration-related, and core AD changes. These brain-defined programs were projected into five whole-blood cohorts (1975 participants) using directional single-sample Gene Set Enrichment Analysis and assessed for stage-specific patterns, comparison with size-matched random sets, sensitivity to estimated cell composition, dimensionality, held-out classification, and association with Alzheimer's Disease Neuroimaging Initiative (ADNI) genetic and fluid biomarkers.

Results

Brain-derived AD programs were detected across blood cohorts and showed a shared rather than separable pattern. Scores were highest at MCI, exceeded size-matched random baselines, and were not primarily explained by estimated blood-cell proportions. In GSE63060, P1/P2/P5 scores formed a dominant axis, with PC1 explaining 92.2% of directional half-score variance. A held-out classifier achieved AUC = 0.822, and ADNI analyses showed information beyond APOE ε4 and improved discrimination when blood scores were combined with cerebrospinal fluid pTau181/Aβ 42 .

Conclusions

Neuropathology-defined AD transcriptomic programs form a shared peripheral axis that is most evident at MCI. This brain-anchored signal adds a systemic transcriptional dimension to genetic and fluid biomarkers and provides a biological framework for studying early AD-related disease in blood.

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Fundamental Research Funds for the Central Universities
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Lu, S., Mao, H., Rui, X., Hou, X., Qian, M., & Wu, X. (2026). Neuropathology-defined Alzheimer's disease transcriptomic programs converge in blood at mild cognitive impairment. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877261507716

Vancouver

Lu S, Mao H, Rui X, Hou X, Qian M, Wu X. Neuropathology-defined Alzheimer's disease transcriptomic programs converge in blood at mild cognitive impairment. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877261507716

BibTeX
@article{Lu2026,
  author = {Lu, Songnian and Mao, Hongyuan and Rui, Xiaoya and Hou, Xiaohui and Qian, Mengcen and Wu, Xingjiao},
  title = {Neuropathology-defined Alzheimer's disease transcriptomic programs converge in blood at mild cognitive impairment},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  doi = {10.1177/13872877261507716}
}
Kostenlos starten →